Table 2.

Correlations of protein expression levels with clinicopathological features

Clinico-path parameters	No of cases (%)	HLAB	14-3-3 β	LTBP-3	ADAMTS2	Wnt-5a	MRLC 2/3	Jagged-2	nm23 H2	SRPX	RECK
Age		0.923	0.273	0.132	0.246	0.437	0.173	0.644	0.745	0.145	0.559
< 65	35 (29)
≥ 65	84 (71)
Gender		0.556	0.363	0.178	0.938	0.562	0.709	0.515	0.866	0.681	0.215
F	59 (50)
M	60 (50)
Tumor location		0.230	0.318	0.231	0.444	0.317	0.078	0.589	0.736	0.534	0.036
Colon	82 (69)
Rectum	37 (31)
Histological type		0.106	0.001*	0.952	0.621	0.192	0.792	0.044*	0.158	0.526	0.659
Non mucinous	102 (86)
Mucinuo	16 (14)
Histological grade		0.020*	0.031*	0.743	0.326	0.266	0.402	0.646	0.032*	0.149	0.327
High grade	95 (81)
Low grade	23 (191)
Vascular invasion		0.556	0.200	0.500	0.730	0.279	0.584	0.038*	0.048*	0.401	0.166
Negative	90 (76)
Positive	29 (24)
Perineural invasion		0.017*	0.466	0.194	0.457	0.300	0.598	0.664	0.080	0.925	0.747
Negative	109 (92)
Positive	9 (8)
TNM stages		0.394	0.226	0.647	0.664	0.508	0.403	0.374	0.147	0.184	0.257
I	20 (17)
II	42 (36)
III	34 (29)
IV	21 (18)
Distant metastasis		0.307	0.850	0.003*	0.013*	0.503	0.833	0.808	0.418	0.681	0.210
No	89 (75)
Yes	29 (25)
Nodal status		0.227	0.417	0.403	0.336	0.894	0.101	0.283	0.413	0.463	0.194
Negative	66 (58)
Positive	47 (42)
Depth of invasion		0.426	0.041*	0.497	0.855	0.095	0.152	0.054	0.092	0.110	0.245
T1/T2	23 (20)
T3/T4	93 (80)
5-year recurrence#		0.104	0.120	0.075	0.041*	0.671	0.781	0.763	0.761	0.673	0.654
Recurrence free	58 (79)
Recurrence	15 (21)
Cause of death		0.025*	0.139	0.005*	0.055	0.380	0.650	0.488	0.144	0.390	0.265
CRC	37 (30)
Other cause	87 (70)

*p < 0.05 is considered significant

# Presence of absence of local or distant metachronous recurrence within 5 year follow-up